Skip Navigation



NDT Advance Access published online on September 17, 2009
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfp495
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Chan, C. T.
Right arrow Articles by Verma, S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chan, C. T.
Right arrow Articles by Verma, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press [on behalf of ERA-EDTA]. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org


Nocturnal haemodialysis is associated with improved vascular smooth muscle cell biology

Christopher T. Chan1, Fina Lovren2, Yi Pan2 and Subodh Verma2

1 Division of Nephrology, University Health Network 2 Division of Cardiac Surgery, St Michael's Hospital, Toronto, Ontario, Canada

Correspondence and offprint requests to: Christopher T. Chan; E-mail: christopher.chan{at}uhn.on.ca



  Abstract

Background. Conventional haemodialysis (CHD) is associated with a reduction in vascular smooth muscle cells (VSMCs) proliferation and an increase in apoptosis.

Methods. VSMC proliferation, migration, apoptosis and Runx2 expression were assessed under normal conditions (n = 4) and before and after conversion from CHD to NHD (n = 15).

Results. Compared to normal, CHD is associated with a reduction in VSMC proliferation [0.49 ± 0.07 (CHD) versus 1.34 ± 0.02 RFU, P < 0.01], an augmented caspase-3 activity [0.30 ± 0.02 (CHD) versus 0.22 ± 0.02 RFU, P = 0.014] and a 1.4 ± 0.3 fold increase in Runx2 expression. After conversion to NHD, VSMC proliferation was higher than during CHD [from 0.49 ± 0.07 (CHD) to 0.68 ± 0.09 RFU, P = 0.006] and approached that of controls (1.34 ± 0.02, P > 0.05). Caspase-3 activity was restored to similar values as controls [0.26 ± 0.02 (NHD) versus 0.22 ± 0.04 (normal), P > 0.05]. Runx2 expression decreased to similar levels as normal controls. NHD enhanced dialysis dose delivery, lowered blood pressure, plasma parathyroid hormone levels and normalized plasma phosphate (from 1.7 ± 0.1 to 1.2 ± 0.1 mmol/L, P < 0.01). The reduction in plasma phosphate correlated with the change in VSMC proliferation (r = –0.71, P = 0.007).

Conclusions. We demonstrate that NHD is associated with restoration of abnormal VSMC biology in ESRD. Given the increasing importance of VSMCs in the pathogenesis of atherosclerosis and medial calcification, these data may have important implications for vascular risk in ESRD patients.

Keywords: apoptosis; nocturnal haemodialysis; phosphate; Runx2; vascular smooth muscle cell

Received for publication: 8. 7.09
Accepted in revised form: 25. 8.09


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.